vs
Hanover Bancorp, Inc.（HNVR）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
Hanover Bancorp, Inc.的季度营收约是SUTRO BIOPHARMA, INC.的1.6倍（$18.6M vs $11.6M），Hanover Bancorp, Inc.同比增速更快（3.3% vs -21.4%），过去两年Hanover Bancorp, Inc.的营收复合增速更高（6.1% vs -5.4%）
汉诺威银行控股公司是总部位于美国马里兰州的区域性银行控股企业，提供零售及商业银行业务，涵盖存款、商业贷款、住房抵押贷款、个人借贷、财富管理等服务，服务对象包括个人消费者、中小企业及本地社区机构，业务覆盖马里兰州及大西洋中部邻近区域。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
HNVR vs STRO — 直观对比
营收规模更大
HNVR
是对方的1.6倍
$11.6M
营收增速更快
HNVR
高出24.7%
-21.4%
两年增速更快
HNVR
近两年复合增速
-5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.6M | $11.6M |
| 净利润 | $33.0K | — |
| 毛利率 | — | — |
| 营业利润率 | 0.7% | — |
| 净利率 | 0.2% | — |
| 营收同比 | 3.3% | -21.4% |
| 净利润同比 | -99.2% | 35.4% |
| 每股收益（稀释后） | $0.00 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HNVRSTRO
| Q4 25 | $18.6M | $11.6M | ||
| Q3 25 | $18.0M | $9.7M | ||
| Q2 25 | $18.4M | $63.7M | ||
| Q1 25 | $18.4M | $17.4M | ||
| Q4 24 | $18.0M | $14.8M | ||
| Q3 24 | $17.1M | $8.5M | ||
| Q2 24 | $16.9M | $25.7M | ||
| Q1 24 | $16.5M | $13.0M |
净利润HNVRSTRO
| Q4 25 | $33.0K | — | ||
| Q3 25 | $3.5M | $-56.9M | ||
| Q2 25 | $2.4M | $-11.5M | ||
| Q1 25 | $1.5M | $-76.0M | ||
| Q4 24 | $3.9M | $-72.4M | ||
| Q3 24 | $3.5M | $-48.8M | ||
| Q2 24 | $844.0K | $-48.0M | ||
| Q1 24 | $4.1M | $-58.2M |
营业利润率HNVRSTRO
| Q4 25 | 0.7% | — | ||
| Q3 25 | 25.9% | -499.9% | ||
| Q2 25 | 18.4% | -5.2% | ||
| Q1 25 | 9.6% | -393.8% | ||
| Q4 24 | 28.9% | -440.7% | ||
| Q3 24 | 27.1% | -797.2% | ||
| Q2 24 | 6.9% | -189.4% | ||
| Q1 24 | 32.7% | -435.0% |
净利率HNVRSTRO
| Q4 25 | 0.2% | — | ||
| Q3 25 | 19.4% | -586.6% | ||
| Q2 25 | 13.3% | -18.0% | ||
| Q1 25 | 8.3% | -436.6% | ||
| Q4 24 | 21.7% | -489.2% | ||
| Q3 24 | 20.7% | -572.6% | ||
| Q2 24 | 5.0% | -186.8% | ||
| Q1 24 | 24.6% | -447.5% |
每股收益（稀释后）HNVRSTRO
| Q4 25 | $0.00 | — | ||
| Q3 25 | $0.47 | $-0.67 | ||
| Q2 25 | $0.33 | $-0.14 | ||
| Q1 25 | $0.20 | $-0.91 | ||
| Q4 24 | $0.52 | $-27.63 | ||
| Q3 24 | $0.48 | $-0.59 | ||
| Q2 24 | $0.11 | $-0.59 | ||
| Q1 24 | $0.55 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $208.9M | $141.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $200.3M | $-132.5M |
| 总资产 | $2.4B | $173.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HNVRSTRO
| Q4 25 | $208.9M | $141.4M | ||
| Q3 25 | $167.6M | $167.6M | ||
| Q2 25 | $164.5M | $205.1M | ||
| Q1 25 | $160.2M | $249.0M | ||
| Q4 24 | $162.9M | $316.9M | ||
| Q3 24 | $141.2M | $388.3M | ||
| Q2 24 | $141.1M | $375.6M | ||
| Q1 24 | $136.5M | $267.6M |
股东权益HNVRSTRO
| Q4 25 | $200.3M | $-132.5M | ||
| Q3 25 | $201.8M | $-87.3M | ||
| Q2 25 | $198.9M | $-32.1M | ||
| Q1 25 | $196.6M | $-25.8M | ||
| Q4 24 | $196.6M | $44.6M | ||
| Q3 24 | $192.3M | $111.2M | ||
| Q2 24 | $190.1M | $152.2M | ||
| Q1 24 | $189.5M | $98.0M |
总资产HNVRSTRO
| Q4 25 | $2.4B | $173.8M | ||
| Q3 25 | $2.3B | $209.7M | ||
| Q2 25 | $2.3B | $262.4M | ||
| Q1 25 | $2.3B | $321.4M | ||
| Q4 24 | $2.3B | $387.2M | ||
| Q3 24 | $2.3B | $451.8M | ||
| Q2 24 | $2.3B | $489.0M | ||
| Q1 24 | $2.3B | $403.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $13.1M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $12.2M | — |
| 自由现金流率自由现金流/营收 | 65.5% | — |
| 资本支出强度资本支出/营收 | 4.7% | — |
| 现金转化率经营现金流/净利润 | 395.48× | — |
| 过去12个月自由现金流最近4个季度 | $16.3M | — |
8季度趋势，按日历期对齐
经营现金流HNVRSTRO
| Q4 25 | $13.1M | $-177.2M | ||
| Q3 25 | $2.7M | $-38.2M | ||
| Q2 25 | $-2.1M | $-44.7M | ||
| Q1 25 | $4.1M | $-67.9M | ||
| Q4 24 | $5.4M | $-71.7M | ||
| Q3 24 | $-547.0K | $-64.5M | ||
| Q2 24 | $-3.1M | $9.5M | ||
| Q1 24 | $3.6M | $-64.7M |
自由现金流HNVRSTRO
| Q4 25 | $12.2M | — | ||
| Q3 25 | $2.4M | — | ||
| Q2 25 | $-2.2M | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $4.1M | — | ||
| Q3 24 | $-876.0K | — | ||
| Q2 24 | $-4.5M | — | ||
| Q1 24 | $3.3M | — |
自由现金流率HNVRSTRO
| Q4 25 | 65.5% | — | ||
| Q3 25 | 13.5% | — | ||
| Q2 25 | -11.7% | — | ||
| Q1 25 | 21.2% | — | ||
| Q4 24 | 23.1% | — | ||
| Q3 24 | -5.1% | — | ||
| Q2 24 | -26.9% | — | ||
| Q1 24 | 19.9% | — |
资本支出强度HNVRSTRO
| Q4 25 | 4.7% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 0.5% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 7.2% | — | ||
| Q3 24 | 1.9% | — | ||
| Q2 24 | 8.6% | — | ||
| Q1 24 | 1.9% | — |
现金转化率HNVRSTRO
| Q4 25 | 395.48× | — | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | -0.84× | — | ||
| Q1 25 | 2.70× | — | ||
| Q4 24 | 1.39× | — | ||
| Q3 24 | -0.15× | — | ||
| Q2 24 | -3.68× | — | ||
| Q1 24 | 0.89× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
